Results 221 to 230 of about 240,659 (269)
Some of the next articles are maybe not open access.

Modeling Pharmacokinetics

2016
Pharmacokinetics is the study of the fate of xenobiotics in a living organism. Physiologically based pharmacokinetic (PBPK) models provide realistic descriptions of xenobiotics' absorption, distribution, metabolism, and excretion processes. They model the body as a set of homogeneous compartments representing organs, and their parameters refer to ...
Bois, Frédéric Y., Brochot, Céline
openaire   +3 more sources

Pharmacokinetics of ceftizoxime

European Journal of Clinical Pharmacology, 1985
The kinetics of ceftizoxime, a newly developed cephalosporin, were evaluated in 6 healthy subjects, with respect to its excretory pathways especially by the biliary route. Total, renal and biliary clearance were determined at two different steady states.
U, Gundert-Remy   +3 more
openaire   +2 more sources

Pharmacokinetics and Immunotoxicity

1980
The possibilities of different actions of xenobiotics on the immunological system are described (different cells with immunocompetence in distinct stages of development, indirect action, pharmacokinetics and especially biotransformation). Results concerning the toxic action and biotransformation are given for DOTC. The atrophy of the thymus produced by
P, Lange, G, Hennighausen, U, Karnstedt
openaire   +2 more sources

Pharmacokinetics of nicorandil

The American Journal of Cardiology, 1989
This report presents the findings of some studies on single intravenous and oral dosing performed in healthy volunteers to determine the pharmacokinetics and preliminary metabolism of nicorandil, a new vasodilator acting via increase of both membrane potassium conductance and intracellular cyclic guanosine monophosphate in vascular smooth muscle ...
Armand M. Frydman   +11 more
openaire   +2 more sources

Pharmacokinetics of rilmenidine

The American Journal of Cardiology, 1988
Rilmenidine, an alpha 2-adrenoceptor agonist, was studied (1 mg single dose) in order to determine the effects of pathology on its basic pharmacokinetic parameters. Because of the mainly renal elimination of rilmenidine, studies involved hypertensive, elderly hypertensive, renal insufficient and hepatic insufficient patients.
E, Singlas   +4 more
openaire   +2 more sources

Pharmacokinetics of methotrexate

Clinical Pharmacology & Therapeutics, 1974
Methotrexate (Mtx) is a competitive inhibitor of the enzymatic activity of dihydrofolate reductase, decreasing the reduction of folic acid to tetrahydrofolate and thereby the activity of thymi dilate kinase. The net effect is a decrease in biosynthesis of deoxyribonucleic acid (DNA) primarily, but also of ribonucleic acid (RNA) and protein. Whereas the
D L, Azarnoff, S H, Wan, D H, Huffman
openaire   +2 more sources

Pharmacokinetics of terazosin

The American Journal of Medicine, 1986
The pharmacokinetics of terazosin have been assessed in human volunteers, hypertensive patients, a limited number of elderly volunteers, and a small number of patients with congestive heart failure. Terazosin was administered intravenously and orally in doses ranging up to 7.5 mg.
openaire   +2 more sources

Pharmacokinetics of the Taxanes

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1997
The pharmacokinetics of the taxanes paclitaxel and docetaxel have been studied extensively in humans. Paclitaxel has distinctly nonlinear pharmacokinetics, with saturable distribution and elimination features. Docetaxel pharmacokinetics are well described by linear processes, although some investigators detected subtle nonlinear characteristics ...
openaire   +2 more sources

Pharmacokinetics of prostaglandins

Best Practice & Research Clinical Obstetrics & Gynaecology, 2003
Naturally occurring prostaglandins (PGs) are rapidly metabolized in the human circulation. For clinical use a number of PG analogues have therefore been developed which are resistant to rapid inactivation. Among these are carboprost, gemeprost and misoprostol.
openaire   +2 more sources

Lamotrigine: Pharmacokinetics

Journal of Child Neurology, 1997
The pharmacokinetics of lamotrigine have been studied in single and multiple dose studies in animals, normal volunteers, and patients with epilepsy. Lamotrigine exhibits first-order linear pharmacokinetics. Lamotrigine is well absorbed with bioavailability approaching 100%. The absorption is unaffected by food and there is no first-pass metabolism. The
openaire   +2 more sources

Home - About - Disclaimer - Privacy